Epygon is the first “physiological” transcatheter mitral prosthesis; it can restore the natural blood flow vortex in the left ventricle, thereby fostering recovery of ventricular function, especially in fragile patients with a seriously impaired cardiac condition.
The new Epygon bio-prosthesis for transapical mitral valve replacement has been designed to ensure superior clinical outcomes in patients with severe mitral regurgitation.
The unique features of the device include a pericardial tissue monoleaflet combined with a D-shaped annular ring. The asymmetric Nitinol frame, with its anatomic anchoring systems, ensures stable coupling below the mitral annulus, captures the native leaflets, and achieves optimal fitting with low risk of LVOT obstruction.
The Epygon design allows restoration of physiologic blood flow in the ventricle and through the aortic valve.
The natural asymmetry of the native valve generates a rotary flow or vortex in the ventricle that minimizes energy loss and helps propel blood directly into the aortic outflow tract.